Clinical Trials in Massachusetts

Showing 8881-8900 of 17,868 trials

Telmisartan Pilot Study on Treatment Resistant Schizophrenia

NCT03868839

This study is a 4-week pilot study for subjects with Schizophrenia or Schizoaffective Disorder who have not experienced a significant relief of symptoms from current anti-psychotic medication. The Investigators hypothesize that 4 weeks of telmisartan at 80mg daily will alter blood biomarkers for inflammation and oxidative stress after 4 weeks treatment.

SchizophreniaSchizo Affective DisorderTreatment-resistant Schizophrenia

Xiaoduo Fan6 participantsStarted Feb 2019

Worcester, Massachusetts, United States

COMPLETEDPhase 318 miles

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)

NCT02227875

To test whether Mylan's insulin glargine once daily is non-inferior to Lantus® once daily (both administered in combination with other anti-diabetic drugs) based on the change in HbA1c from baseline to 24 weeks

Type 2 Diabetes

Mylan Inc.560 participantsStarted Aug 2014

Chandler, Arizona, United States • Bell Gardens, California, United States • Fresno, California, United States +117 more locations

Telmisartan Pilot Study on Treatment Resistant Schizophrenia

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)

Find Trials by Condition in Massachusetts

Mylan Insulin Aspart Study

A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults

LFMS: Initial Trial in Geriatric Bipolar Depression

Pre Bypass Ultrafiltration (PBUF) in Children Requiring Cardiopulmonary Bypass

Pharmacological Intervention for Symptomatic Mild Sleep Disordered Breathing

Zilver® PTX® V Clinical Study

Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients

Photobiomodulation to Improve Cognition in TBI, With fMRI

A Pilot Study of BXCL701 in Patients With Pancreatic Cancer

Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

Clinical Concordance Evaluation of T-SPOT®.TB Assay Performance (T-Cell SelectTM Study)

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)

Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer

Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder Cancer

Safety and Efficacy of AMG 827 in Subjects With RA

SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide

A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis